OrthogenRx, Inc. is a medical device company focused on the development and commercialization of treatments for musculoskeletal conditions including osteoarthritis (OA).
Location: United States, Pennsylvania, Doylestown Township
Total raised: $2.2M
Investors 2
Date | Name | Website |
- | Ben Frankl... | sep.benfra... |
- | New Age Ve... | newagevent... |
Funding Rounds 1
Date | Series | Amount | Investors |
18.05.2017 | Seed | $2.2M | - |
Mentions in press and media 2
Date | Title | Description | Source |
07.10.2015 | GenVisc 850 Approved by the FDA for Treatment of Osteoarthri... | DOYLESTOWN, Pa.–(BUSINESS WIRE)–October 7, 2015– OrthogenRx Inc. has announced the US Food and Drug... | venturebea... |
11.12.2014 | Updated: Ben Franklin Approves $2.8M for Sixteen Early-Stage... | Advent Therapeutics focuses on providing therapies for micro-orphan applications. The company ... | sep.benfra... |